12th recommendation for inclusion in Annex XIV published on ECHA’s website
ECHA recommends adding four new substances, including melamine, to Annex XIV
15 Dec 2025On November 18, the 12th recommendation for the inclusion in Annex XIV of four new substances, including melamine, in the list of substances subject to REACH authorisation was published on ECHA’s website. Once included, companies will have to apply for authorisation to continue using them.
The substances proposed for inclusion in Annex XIV are as follows:
|
Name |
CAS/EC |
Hazard |
Main use |
|
Melamine |
108-78-1 |
A combination of very high persistence, high mobility in water, potential for being transported in the water phase over long distances and toxicity |
Monomer for the production of polymers and resins. Additive in foams, resins, paints and coatings. May be present in materials such as wood, plastic, metals, leather/hide, textiles. |
|
S-(tricyclo[5.2.1.0 2,6]deca-3-en-8(or 9)-yl) O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2- ethylhexyl) phosphorodithioate |
255881-94-8 |
PBT |
Component of fats and lubricants. |
|
Diphenyl(2,4,6- trimethylbenzoyl)phosphi ne oxide |
75980-60-8 |
Toxic for reproduction Category 1B |
Component of inks, toners, paints, coatings and adhesives. Photoinitiator in inks, adhesives and coatings. Process regulator in the polymerisation of resins, rubbers and plastics. |
|
Barium diboron tetraoxide |
13701-59-2 |
Toxic for reproduction Category 1B |
Component of inks, thinners, paints and paint strippers. |
Although melamine was the subject of extensive comments during the 2024 consultation, ECHA, after careful consideration, nevertheless decided to confirm its recommendation for inclusion.
In most applications, melamine is used as an intermediate (which does not require authorisation), but for other uses, authorisation will be necessary, potentially creating significant challenges for companies and authorities.
Purpose of the authorisation process: to promote the substitution of substances of very high concern when technically and economically feasible alternatives exist, while ensuring proper risk control for human health and the environment in the meantime.
This recommendation marks an important step towards stronger health and environmental protection in the EU. Companies using these substances should closely monitor the Commission’s decisions and plan ahead for potential authorisation requests or substitution strategies. Acting now will help minimise operational risks and ensure regulatory compliance in an increasingly sustainability-driven context.